Literature DB >> 29109605

Brexpiprazole for schizophrenia.

.   

Abstract

Entities:  

Year:  2017        PMID： 29109605      PMCID： PMC5662434          DOI： 10.18773/austprescr.2017.064

Source DB:  PubMed          Journal:  Aust Prescr        ISSN： 0312-8008


× No keyword cloud information.
  5 in total

1.  A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia.

Authors:  John M Kane; Aleksandar Skuban; John Ouyang; Mary Hobart; Stephanie Pfister; Robert D McQuade; Margaretta Nyilas; William H Carson; Raymond Sanchez; Hans Eriksson
Journal:  Schizophr Res       Date:  2015-02-12       Impact factor: 4.939

2.  The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia: results from a randomized, exploratory study.

Authors:  Leslie Citrome; Ai Ota; Kazuhiro Nagamizu; Pamela Perry; Emmanuelle Weiller; Ross A Baker
Journal:  Int Clin Psychopharmacol       Date:  2016-07       Impact factor: 1.659

3.  Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Christoph U Correll; Aleksandar Skuban; John Ouyang; Mary Hobart; Stephanie Pfister; Robert D McQuade; Margaretta Nyilas; William H Carson; Raymond Sanchez; Hans Eriksson
Journal:  Am J Psychiatry       Date:  2015-04-16       Impact factor: 18.112

Review 4.  Overview of short- and long-term tolerability and safety of brexpiprazole in patients with schizophrenia.

Authors:  John M Kane; Aleksandar Skuban; Mary Hobart; John Ouyang; Emmanuelle Weiller; Catherine Weiss; Christoph U Correll
Journal:  Schizophr Res       Date:  2016-05-14       Impact factor: 4.939

5.  Efficacy and Safety of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults with Schizophrenia: a Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  W Wolfgang Fleischhacker; Mary Hobart; John Ouyang; Andy Forbes; Stephanie Pfister; Robert D McQuade; William H Carson; Raymond Sanchez; Margareta Nyilas; Emmanuelle Weiller
Journal:  Int J Neuropsychopharmacol       Date:  2017-01-01       Impact factor: 5.176
  5 in total
  1 in total

Review 1.  A Review of the Pharmacological and Clinical Profile of Newer Atypical Antipsychotics as Treatments for Bipolar Disorder: Considerations for Use in Older Patients.

Authors:  Akshya Vasudev; Sumit Chaudhari; Rickinder Sethi; Rachel Fu; Rachel M Sandieson; Brent P Forester
Journal:  Drugs Aging       Date:  2018-10       Impact factor: 3.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.